RIGL EPS Estimates
Rigel Pharmaceuticals, Inc.
$46.82
-$0.32(-0.68%)
69
Overall
80
Value
63
Tech
65
Quality
Market Cap
$874.59M
Volume
159.95K
52W Range
$24.95 - $52.24
Target Price
$63.00
RIGL EPS estimates: the consensus estimate for Rigel Pharmaceuticals, Inc.'s current fiscal year is $2.98 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
RIGL EPS Estimates
- EPS estimate, current quarter
- $0.87
- EPS estimate, next quarter
- $0.93
- EPS estimate, current year
- $2.98
- EPS estimate, next year
- $4.32
- EPS growth, 3-year
- +100.00%
| Fiscal year | EPS |
|---|---|
| 2025 | $20.40 |
| 2024 | $0.99 |
| 2023 | $-1.40 |
| 2022 | $-3.40 |
| 2021 | $-0.11 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RIGL | $46.82 | -0.7% | 159.95K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Rigel Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW